Key drivers of the global alopecia areata market include an increase in the geriatric population and rise in the prevalence of alopecia conditions. However, the market faces challenges such as patent expiration and existence of alternative treatment options. In addition, advancements in topical immunotherapy, which aims to retrain the immune system to stop attacking hair follicles, offer further avenues for treatment. The benefits of this market extend beyond just hair regrowth. Effective alopecia areata treatments can significantly improve a patient's quality of life by boosting self-esteem and reducing the psychological impact of hair loss.
Frequently Asked Questions
The market is segmented based on Segmentation, By Disease Type (Alopecia Areata (Patchy), Alopecia Areata Totalis, Alopecia Areata Universalis, and Others), Cause (Non-Genetic and Genetic), Type (Treatment and Diagnosis), Age Group (Below 18 Years, 18-50 Years, and Above 50 Years), Gender (Female and Male) – Industry Trends and Forecast to 2032
.
The Global Alopecia Areata Market size was valued at USD 10.37 USD Billion in 2024.
The Global Alopecia Areata Market is projected to grow at a CAGR of 8.13% during the forecast period of 2025 to 2032.
The major players operating in the market include Pfizer Inc., Dr. Reddys Laboratories Ltd., Lilly, Sun Pharmaceutical Industries Ltd., GSK plc., Johnson & Johnson Consumer Inc., Lupin, Croma-Pharma GmbH, Viviscal Limited , AdvaCare Pharma, Wellona Pharma, Teva Pharmaceuticals USAInc., Croma-Pharma GmbH, Follicum AB, Nanogen, Vitabiotics Ltd., Reistone Biopharma, and TechnoDerma Medicines Inc.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
